| 1 | dependent | 6,165 |
| 2 | contingent | 295 |
| 3 | dependant | 60 |
| 4 | reliant | 50 |
| 5 | incumbent | 23 |
| 6 | 3-dependent | 13 |
| 7 | encroaching | 8 |
| 8 | pathway-dependent | 7 |
| 9 | pinned | 6 |
| 10 | co-dependent | 5 |
| 11 | preyed | 4 |
| 12 | hole-doped | 3 |
| 13 | non-predictive | 3 |
| 14 | polysubstance-using | 3 |
| 15 | 183,000 | 2 |
| 16 | 8-dependent | 2 |
| 17 | depolymerised | 2 |
| 18 | diabeticorum | 2 |
| 19 | heterotrophically | 2 |
| 20 | no-face | 2 |
| 21 | non-deliberative | 2 |
| 22 | notch-2 | 2 |
| 23 | placebo.based | 2 |
| 24 | pre-mounted | 2 |
| 25 | refundable | 2 |
| 26 | tortoise | 2 |
| 27 | transgressing | 2 |
| 28 | well-read | 2 |
| 29 | 1/2↔3/2 | 1 |
| 30 | 2,582 | 1 |
| 31 | 3,751 | 1 |
| 32 | 41:59 | 1 |
| 33 | 4b/a | 1 |
| 34 | 8.5min | 1 |
| 35 | actiwatch® | 1 |
| 36 | additive-a | 1 |
| 37 | bap/untx | 1 |
| 38 | cdi-related | 1 |
| 39 | dependent-functional | 1 |
| 40 | drug-challenge | 1 |
| 41 | echthronomas | 1 |
| 42 | fe-vacancy | 1 |
| 43 | flow-reserve | 1 |
| 44 | formalin-evoked | 1 |
| 45 | frame.based | 1 |
| 46 | frowns | 1 |
| 47 | g-703t-polymorphism | 1 |
| 48 | glu420 | 1 |
| 49 | h-moderate-intensity-exercise | 1 |
| 50 | hsco | 1 |
| 51 | hyperapob-based | 1 |
| 52 | i-independent | 1 |
| 53 | intoxication-the | 1 |
| 54 | kinrix™+mmr | 1 |
| 55 | morphine/oxycodone-treated | 1 |
| 56 | nonpropagative | 1 |
| 57 | outcome/disease | 1 |
| 58 | outward-rectified | 1 |
| 59 | phe-218 | 1 |
| 60 | pjms | 1 |
| 61 | pore-formation | 1 |
| 62 | production-dependent | 1 |
| 63 | prolix | 1 |
| 64 | recurved | 1 |
| 65 | reposing | 1 |
| 66 | saprobe | 1 |
| 67 | sickle-shaped | 1 |
| 68 | slt2-dependent | 1 |
| 69 | spent/patient | 1 |
| 70 | spirochetemic | 1 |
| 71 | stable/symptomatic | 1 |
| 72 | step-economical | 1 |
| 73 | tolerance/type-2 | 1 |
| 1 | 1/2↔3/2 | 1 |
| 2 | 183,000 | 2 |
| 3 | 2,582 | 1 |
| 4 | 3,751 | 1 |
| 5 | 3-dependent | 13 |
| 6 | 41:59 | 1 |
| 7 | 4b/a | 1 |
| 8 | 8-dependent | 2 |
| 9 | 8.5min | 1 |
| 10 | actiwatch® | 1 |
| 11 | additive-a | 1 |
| 12 | bap/untx | 1 |
| 13 | cdi-related | 1 |
| 14 | co-dependent | 5 |
| 15 | contingent | 295 |
| 16 | dependant | 60 |
| 17 | dependent | 6,165 |
| 18 | dependent-functional | 1 |
| 19 | depolymerised | 2 |
| 20 | diabeticorum | 2 |
| 21 | drug-challenge | 1 |
| 22 | echthronomas | 1 |
| 23 | encroaching | 8 |
| 24 | fe-vacancy | 1 |
| 25 | flow-reserve | 1 |
| 26 | formalin-evoked | 1 |
| 27 | frame.based | 1 |
| 28 | frowns | 1 |
| 29 | g-703t-polymorphism | 1 |
| 30 | glu420 | 1 |
| 31 | h-moderate-intensity-exercise | 1 |
| 32 | heterotrophically | 2 |
| 33 | hole-doped | 3 |
| 34 | hsco | 1 |
| 35 | hyperapob-based | 1 |
| 36 | i-independent | 1 |
| 37 | incumbent | 23 |
| 38 | intoxication-the | 1 |
| 39 | kinrix™+mmr | 1 |
| 40 | morphine/oxycodone-treated | 1 |
| 41 | no-face | 2 |
| 42 | non-deliberative | 2 |
| 43 | non-predictive | 3 |
| 44 | nonpropagative | 1 |
| 45 | notch-2 | 2 |
| 46 | outcome/disease | 1 |
| 47 | outward-rectified | 1 |
| 48 | pathway-dependent | 7 |
| 49 | phe-218 | 1 |
| 50 | pinned | 6 |
| 51 | pjms | 1 |
| 52 | placebo.based | 2 |
| 53 | polysubstance-using | 3 |
| 54 | pore-formation | 1 |
| 55 | pre-mounted | 2 |
| 56 | preyed | 4 |
| 57 | production-dependent | 1 |
| 58 | prolix | 1 |
| 59 | recurved | 1 |
| 60 | refundable | 2 |
| 61 | reliant | 50 |
| 62 | reposing | 1 |
| 63 | saprobe | 1 |
| 64 | sickle-shaped | 1 |
| 65 | slt2-dependent | 1 |
| 66 | spent/patient | 1 |
| 67 | spirochetemic | 1 |
| 68 | stable/symptomatic | 1 |
| 69 | step-economical | 1 |
| 70 | tolerance/type-2 | 1 |
| 71 | tortoise | 2 |
| 72 | transgressing | 2 |
| 73 | well-read | 2 |
| 1 | 183,000 | 2 |
| 2 | glu420 | 1 |
| 3 | 3,751 | 1 |
| 4 | tolerance/type-2 | 1 |
| 5 | notch-2 | 2 |
| 6 | 1/2↔3/2 | 1 |
| 7 | 2,582 | 1 |
| 8 | phe-218 | 1 |
| 9 | 41:59 | 1 |
| 10 | additive-a | 1 |
| 11 | 4b/a | 1 |
| 12 | spirochetemic | 1 |
| 13 | stable/symptomatic | 1 |
| 14 | well-read | 2 |
| 15 | outward-rectified | 1 |
| 16 | formalin-evoked | 1 |
| 17 | pinned | 6 |
| 18 | sickle-shaped | 1 |
| 19 | hole-doped | 3 |
| 20 | hyperapob-based | 1 |
| 21 | frame.based | 1 |
| 22 | placebo.based | 2 |
| 23 | depolymerised | 2 |
| 24 | morphine/oxycodone-treated | 1 |
| 25 | cdi-related | 1 |
| 26 | pre-mounted | 2 |
| 27 | recurved | 1 |
| 28 | preyed | 4 |
| 29 | saprobe | 1 |
| 30 | no-face | 2 |
| 31 | drug-challenge | 1 |
| 32 | intoxication-the | 1 |
| 33 | refundable | 2 |
| 34 | outcome/disease | 1 |
| 35 | h-moderate-intensity-exercise | 1 |
| 36 | tortoise | 2 |
| 37 | nonpropagative | 1 |
| 38 | non-deliberative | 2 |
| 39 | non-predictive | 3 |
| 40 | flow-reserve | 1 |
| 41 | encroaching | 8 |
| 42 | reposing | 1 |
| 43 | transgressing | 2 |
| 44 | polysubstance-using | 3 |
| 45 | step-economical | 1 |
| 46 | dependent-functional | 1 |
| 47 | g-703t-polymorphism | 1 |
| 48 | diabeticorum | 2 |
| 49 | 8.5min | 1 |
| 50 | pore-formation | 1 |
| 51 | hsco | 1 |
| 52 | kinrix™+mmr | 1 |
| 53 | echthronomas | 1 |
| 54 | pjms | 1 |
| 55 | frowns | 1 |
| 56 | dependant | 60 |
| 57 | reliant | 50 |
| 58 | incumbent | 23 |
| 59 | dependent | 6,165 |
| 60 | slt2-dependent | 1 |
| 61 | 3-dependent | 13 |
| 62 | 8-dependent | 2 |
| 63 | production-dependent | 1 |
| 64 | co-dependent | 5 |
| 65 | pathway-dependent | 7 |
| 66 | i-independent | 1 |
| 67 | contingent | 295 |
| 68 | spent/patient | 1 |
| 69 | prolix | 1 |
| 70 | bap/untx | 1 |
| 71 | fe-vacancy | 1 |
| 72 | heterotrophically | 2 |
| 73 | actiwatch® | 1 |